Olga‐Demetra Biziotis

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

Amr Ali, Bassem Mekhaeil, Olga‐Demetra Biziotis et al. · Communications Biology · 2023 · 52 citations · Full text

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α

Olga‐Demetra Biziotis, Evangelia E. Tsakiridis, Amr Ali et al. · Molecular Oncology · 2023 · 31 citations · Full text

Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses

Evangelia E. Tsakiridis, Lindsay A. Broadfield, Katarina Marcinko et al. · Translational Oncology · 2021 · 16 citations · Full text